Skip to content
DataLookout
Menu

NCT07788157

Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Sep 30, 2026 to Dec 30, 2026
  2. Notable Recruitment opened Show 6 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Primary completion moved earlier from Dec 31, 2026 to Sep 30, 2026
    • Study completion moved earlier from Jan 31, 2027 to Dec 31, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 1, 2026 to Jul 12, 2026
    • Secondary endpoints: 10 to 9
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The score of the Wormald scale
Timeframe: From the start of surgery to the end of surgery
The score of the Boezaart scale
Timeframe: From the start of surgery to the end of surgery

Secondary (9)

Total blood loss
The rate of bleeding
Induction time
Extubation time
Emergence time
Show 4 moreShow less
PACU length of stay
Emergence agitation
Postoperative pain score
Postoperative nausea and vomiting (PONV)

Arms and interventions

Group PActive comparator

Propofol induction (1-2 mg/kg) and propofol maintenance (5-12 mg/kg/h).

Group FExperimental

Fospropofol disodium induction (10-20 mg/kg) and fospropofol disodium maintenance (5-12 mg/kg/h).

Group PSExperimental

Propofol induction (1-2 mg/kg) and maintenance with propofol plus sevoflurane (1.0%).

Group FSExperimental

Fospropofol disodium induction (10-20 mg/kg) and maintenance with fospropofol disodium plus sevoflurane (1.0%).

Drugs: Fospropofol disodium, Propofol

Sites

1 site in 1 country

  • Tongji HospitalWuhan, Hubei, China